1-4 of 4
ADVANCE Collaborative Group
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial

Toshiaki Ohkuma, Katie Harris, Mark Woodward, Pavel Hamet, Stephen Harrap, Giuseppe Mancia, Michel Marre, Neil Poulter, John Chalmers, Sophia Zoungas, ADVANCE Collaborative Group
Journal: Diabetes Care
Diabetes Care 2025;48(2):279–284
https://doi.org/10.2337/dc24-1516
Published: 11 December 2024
View article titled, Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial
Open the PDF for Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial in another window
Journal Articles

Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study

Jamie Morton, MBBS, Sophia Zoungas, PHD, Qiang Li, MBIOSTAT, Anushka A. Patel, PHD, John Chalmers, PHD, Mark Woodward, PHD, David S. Celermajer, PHD, Joline W.J. Beulens, PHD, Ronald P. Stolk, PHD, Paul Glasziou, PHD, Martin K.C. Ng, PHD, on behalf of the ADVANCE Collaborative Group
Journal: Diabetes Care
Diabetes Care 2012;35(11):2201–2206
https://doi.org/10.2337/dc12-0306
Published: 13 October 2012
View article titled, Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: <subtitle>Results of the ADVANCE study</subtitle>
Open the PDF for Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: <subtitle>Results of the ADVANCE study</subtitle> in another window
Includes: Supplementary data
Journal Articles

A Summary of the ADVANCE Trial

Simon R. Heller, DM, FRCP, on behalf of the ADVANCE Collaborative Group
Journal: Diabetes Care
Diabetes Care 2009;32(suppl_2):S357–S361
https://doi.org/10.2337/dc09-S339
Published: 01 November 2009
View article titled, A Summary of the ADVANCE Trial
Open the PDF for A Summary of the ADVANCE Trial in another window
Journal Articles

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial

Sophia Zoungas, MD, PHD, Bastiaan E. de Galan, MD, PHD, Toshiharu Ninomiya, MD, PHD, Diederick Grobbee, MD, PHD, Pavel Hamet, MD, PHD, Simon Heller, MD, Stephen MacMahon, DSC, PHD, Michel Marre, MD, PHD, Bruce Neal, MD, PHD, Anushka Patel, MD, PHD, Mark Woodward, PHD, John Chalmers, MD, PHD, on behalf of the ADVANCE Collaborative Group
Journal: Diabetes Care
Diabetes Care 2009;32(11):2068–2074
https://doi.org/10.2337/dc09-0959
Published: 03 August 2009
View article titled, Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: <subtitle>New results from the ADVANCE trial</subtitle>
Open the PDF for Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: <subtitle>New results from the ADVANCE trial</subtitle> in another window
Includes: Supplementary data